PRINCIPAL SECURITIES, INC.

Broker-Dealer

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 12600 DES MOINES, IA

Position in REGN

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$640,999

-$93,009 QoQ

Shares Held

1,028

+8.2% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#743

of 1,322 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

PRINCIPAL SECURITIES, INC. holds $9,913,561 across 11 Biotechnology names. REGN ranks #5 (6.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	5,982	$2,971,438
2	RPRX	Royalty Pharma plc	35,574	$1,994,634
3	ARGX	Argenx SE	1,295	$1,201,462
4	INSM	INSMED Inc	6,728	$717,339
5	REGN	Regeneron Pharmaceuticals, Inc. This page	1,028	$640,999
6	EXEL	Exelixis, Inc.	11,237	$611,405
7	CORT	Corcept Therapeutics Inc	5,720	$497,354
8	ALNY	Alnylam Pharmaceuticals, Inc.	1,389	$418,130

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$640,999	1,028	+8.2%	Shares	Sole	2026-08-04
2026-03-31	$734,008	950	+11.5%	Shares	Sole	2026-05-13
2025-12-31	$657,633	852	-11.4%	Shares	Sole	2026-02-12
2025-09-30	$540,903	962	+0.4%	Shares	Sole	2025-11-12
2025-06-30	$502,950	958	+6.7%	Shares	Sole	2025-08-11
2025-03-31	$569,538	898	0.0%	Shares	Sole	2025-04-30
2024-12-31	$639,672	898	+43.9%	Shares	Sole	2025-01-30
2024-09-30	$655,973	624	+28.9%	Shares	Sole	2024-10-28
2024-06-30	$508,698	484	+30.1%	Shares	Sole	2024-07-31
2024-03-31	$358,046	372	+16.6%	Shares	Sole	2024-05-10
2023-12-31	$280,174	319	—	Shares	Sole	2024-05-10
No filing history on record for this holder in this stock.